ArticleF1000Research2019

Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence.

Laura McCulloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.